Vidium SAS

Startup

Vidium introduces a groundbreaking technology that enables the control and mastery of cellular genetic expression, accelerating and de-risking the development of innovative treatments. Our goal at Vidium is to revolutionize drug discovery by shifting the focus from a single molecular target to the underlying causal gene regulatory network of the cell. Inspired by aeronautics, we have developed a unique retro-engineering platform that deciphers the dynamic and stochastic behavior of gene expression, allowing us to control cell fate like never before. Think of us as a genetic "Waze" that uses white-box models to navigate complex networks of gene interactions and identify specific, validated targets within a few months.

Get involved at BioTechX

 

 

TO SPONSOR


Alistair Wilmot

alistair.wilmot@terrapinn.com

 

Danielle Thomas
danielle.thomas@terrapinn.com

 

TO SPEAK


Joanna Magaji

joanna.magaji@terrapinn.com

 

Taira Marshall
taira.marshall@terrapinn.com

 

MARKETING OPPORTUNITIES


Diana Cobzac

diana.cobzac@terrapinn.com